Outcomes of Hematopoietic Cell Transplantation Using Donors or Recipients with Inherited Chromosomally Integrated HHV-6
Overview
Authors
Affiliations
Human herpesvirus 6 (HHV-6) species have a unique ability to integrate into chromosomal telomeres. Mendelian inheritance via gametocyte integration results in HHV-6 in every nucleated cell. The epidemiology and clinical effect of inherited chromosomally integrated HHV-6 (iciHHV-6) in hematopoietic cell transplant (HCT) recipients is unclear. We identified 4319 HCT donor-recipient pairs (8638 subjects) who received an allogeneic HCT and had archived pre-HCT peripheral blood mononuclear cell samples. We screened these samples for iciHHV-6 and compared characteristics of HCT recipients and donors with iciHHV-6 with those of recipients and donors without iciHHV-6, respectively. We calculated Kaplan-Meier probability estimates and Cox proportional hazards models for post-HCT outcomes based on recipient and donor iciHHV-6 status. We identified 60 HCT recipients (1.4%) and 40 donors (0.9%) with iciHHV-6; both recipient and donor harbored iciHHV-6 in 13 HCTs. Thus, there were 87 HCTs (2%) in which the recipient, donor, or both harbored iciHHV-6. Acute graft-versus-host disease (GVHD) grades 2-4 was more frequent when recipients or donors had iciHHV-6 (adjusted hazard ratios, 1.7-1.9; = .004-.001). Cytomegalovirus viremia (any and high-level) was more frequent among recipients with iciHHV-6 (adjusted HRs, 1.7-3.1; = .001-.040). Inherited ciHHV-6 status did not significantly affect risk for chronic GVHD, hematopoietic cell engraftment, overall mortality, or nonrelapse mortality. Screening for iciHHV-6 could guide donor selection and post-HCT risk stratification and treatment. Further study is needed to replicate these findings and identify potential mechanisms.
Pooled screening for endogenous HHV-6 in subjects with coronary artery disease.
Koide R, Nakashima Y, Kojima S, Sotomi Y, Sakata Y, Sakata Y Virus Genes. 2025; .
PMID: 39890712 DOI: 10.1007/s11262-025-02134-6.
Terao T, Matsuoka K, Fuji S, Kawamura S, Toya T, Doki N Bone Marrow Transplant. 2024; 59(9):1224-1231.
PMID: 38796633 DOI: 10.1038/s41409-024-02313-3.
Hannolainen L, Pyoria L, Pratas D, Lohi J, Skuja S, Rasa-Dzelzkaleja S J Infect Dis. 2024; 231(2):e267-e276.
PMID: 38768311 PMC: 11841639. DOI: 10.1093/infdis/jiae268.
Kampouri E, Handley G, Hill J Viruses. 2024; 16(4).
PMID: 38675841 PMC: 11054085. DOI: 10.3390/v16040498.
Nakano N, Nakasone H, Fuji S, Shinohara A, Suzuki R, Utsunomiya A Lancet Reg Health West Pac. 2023; 40:100902.
PMID: 38106528 PMC: 10721504. DOI: 10.1016/j.lanwpc.2023.100902.